# Biogen (BIIB) — News

BIIB · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/biib/news

## Recent headlines

- [BioGen expects about $35M expense to be recognized in 4Q](https://www.ainvest.com/news/biogen-expects-35m-expense-recognized-4q-2610) — AInvest Wire, Oct 15, 2026
  Biogen Inc. (BIIB) is projected to recognize approximately $35 million in expenses during the fourth quarter of 2026, according to recent financial updates and analyst forecasts. This expense is part of the company’s broader financial strategy, which includes cost-cutting measures and investments…
- [BioGen expects impact non-GAAP net income/shr by about $1.70](https://www.ainvest.com/news/biogen-expects-impact-gaap-net-income-shr-1-70-2610) — AInvest Wire, Oct 15, 2026
- [BioGen expects 3Q of include expense of about $284M](https://www.ainvest.com/news/biogen-expects-3q-include-expense-284m-2610) — AInvest Wire, Oct 15, 2026
  Biogen Inc. (NASDAQ: BIIB) is anticipated to report its third-quarter 2026 earnings on October 28, 2026, before the market opens, according to historical reporting patterns and analyst expectations . The company is expected to include a non-recurring expense of approximately $284 million in its Q3…
- [Alzheimer stocks rose in regular trading, with Eli Lilly up 4.3%, Anavex Life Sciences gaining 3.7% and Biogen rising 3.3%.](https://www.ainvest.com/news/alzheimer-stocks-rose-regular-trading-eli-lilly-4-3-anavex-life-sciences-gaining-3-7-biogen-rising-3-3-2610-18) — AInvest Wire, Oct 15, 2026
  Alzheimer’s-related stocks saw gains in regular trading on October 15, 2026, with Eli Lilly rising 4.3%, Anavex Life Sciences up 3.7%, and Biogen increasing by 3.3%. The movement reflects investor interest in the sector, particularly in companies advancing therapies for neurodegenerative diseases.…
- [Alzheimer stocks rose in regular trading, with Eli Lilly up 3.4%, Biogen gaining 1.6% and Prothena rising 1.2%.](https://www.ainvest.com/news/alzheimer-stocks-rose-regular-trading-eli-lilly-3-4-biogen-gaining-1-6-prothena-rising-1-2-2610) — AInvest Wire, Oct 14, 2026
  Alzheimer's-related stocks experienced gains in regular trading on October 14, 2026, reflecting ongoing investor interest in the sector. Eli Lilly shares rose 3.4%, Biogen increased by 1.6%, and Prothena Corporation (PRTA) added 1.2% to its value. These movements occurred amid continued research…

## Similar Stocks

- [LLY](https://www.lighthorse.io/tickers/lly) — Eli Lilly and Company Common Stock
- [IONS](https://www.lighthorse.io/tickers/ions) — Ionis Pharmaceuticals, Inc. - Common Stock
- [AMGN](https://www.lighthorse.io/tickers/amgn) — Amgen Inc. - Common Stock
- [VRTX](https://www.lighthorse.io/tickers/vrtx) — Vertex Pharmaceuticals Incorporated - Common Stock
- [PRTA](https://www.lighthorse.io/tickers/prta) — Prothena Corporation plc - Ordinary Shares
- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock
- [GILD](https://www.lighthorse.io/tickers/gild) — Gilead Sciences, Inc. - Common Stock
- [BMY](https://www.lighthorse.io/tickers/bmy) — Bristol-Myers Squibb Company Common Stock
- [ABBV](https://www.lighthorse.io/tickers/abbv) — AbbVie Inc. Common Stock
- [JNJ](https://www.lighthorse.io/tickers/jnj) — Johnson & Johnson Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).